據澳新食品標準局（FSANZ）消息，8月21日澳新食品標準局發布[22-17]號通報，應新西蘭初級產業部的請求，將就L-氨基酸酯（L-amino acid acetate）用于特殊醫學用途食品征求意見。有關人員可于2017年8月28日之前提交意見。
在此之前，《澳新食品標準法典》2.9.5號標準附件29-20已批準L-賴氨酸醋酸酯用于特醫食品（L-賴氨酸醋酸酯為L-氨基酸酯的一種）。風險評估結論認為，L-氨基酸酯用于特醫食品無健康風險。新西蘭初級產業部提出本次請求，旨在保障人體健康，并消除對貿易的不良影響。
部分原文報道如下：
FSANZ is considering an urgent Proposal prepared to remove a negative effect on trade in food for special medical purposes and has prepared a draft food regulatory measure. Pursuant to section 96 of the Food Standards Australia New Zealand Act 1991 （FSANZ Act）， FSANZ now calls for submissions to assist its consideration of that draft food regulatory measure.
The Proposal has been declared an urgent Proposal for the purposes of Division 4 of Part 3 of the Food Standards Australia New Zealand Act 1991 （Cth） （the FSANZ Act）.
Standard 2.9.5 and Schedule 29-20 of the Code currently permit L-lysine acetate as the only acetate form of single L-amino acids for use in FSMP.
本文由食品伙伴網食品資訊中心編輯，供網友參考，歡迎轉載，轉載請注明出處！有任何疑問，請聯系news@foodmate.net。
日期：2017-08-25
在此之前，《澳新食品標準法典》2.9.5號標準附件29-20已批準L-賴氨酸醋酸酯用于特醫食品（L-賴氨酸醋酸酯為L-氨基酸酯的一種）。風險評估結論認為，L-氨基酸酯用于特醫食品無健康風險。新西蘭初級產業部提出本次請求，旨在保障人體健康，并消除對貿易的不良影響。
部分原文報道如下：
FSANZ is considering an urgent Proposal prepared to remove a negative effect on trade in food for special medical purposes and has prepared a draft food regulatory measure. Pursuant to section 96 of the Food Standards Australia New Zealand Act 1991 （FSANZ Act）， FSANZ now calls for submissions to assist its consideration of that draft food regulatory measure.
The Proposal has been declared an urgent Proposal for the purposes of Division 4 of Part 3 of the Food Standards Australia New Zealand Act 1991 （Cth） （the FSANZ Act）.
Standard 2.9.5 and Schedule 29-20 of the Code currently permit L-lysine acetate as the only acetate form of single L-amino acids for use in FSMP.
本文由食品伙伴網食品資訊中心編輯，供網友參考，歡迎轉載，轉載請注明出處！有任何疑問，請聯系news@foodmate.net。
日期：2017-08-25
